Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    July 2017
  1. ZHOU Y, Ji Z, Yan W, Zhou Z, et al
    The biological functions and mechanism of miR212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
    Oncol Rep. 2017 Jul 12. doi: 10.3892/or.2017.5805.
    PubMed     Text format     Abstract available


    June 2017
  2. ZHOU Y, Ji Z, Yan W, Zhou Z, et al
    Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
    Oncol Rep. 2017 Jun 29. doi: 10.3892/or.2017.5768.
    PubMed     Text format     Abstract available


  3. XUAN Q, Zhong X, Li W, Mo Z, et al
    CtBP2 is associated with angiogenesis and regulates the apoptosis of prostate cancer cells.
    Oncol Rep. 2017 Jun 28. doi: 10.3892/or.2017.5763.
    PubMed     Text format     Abstract available


    May 2017
  4. HATA S, Nomura T, Iwasaki K, Sato R, et al
    Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer.
    Oncol Rep. 2017 May 24. doi: 10.3892/or.2017.5669.
    PubMed     Text format     Abstract available


  5. LIU L, Lou N, Li X, Xu G, et al
    Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells.
    Oncol Rep. 2017 May 4. doi: 10.3892/or.2017.5623.
    PubMed     Text format     Abstract available


  6. BAI S, Chen T, Yu X, Luo M, et al
    The specific killing effect of matrine on castration-resistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway.
    Oncol Rep. 2017;37:2819-2828.
    PubMed     Text format     Abstract available


    April 2017
  7. YIN B, Liu Z, Wang Y, Wang X, et al
    RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells.
    Oncol Rep. 2017 Apr 19. doi: 10.3892/or.2017.5585.
    PubMed     Text format     Abstract available


    March 2017
  8. ZHAO Y, Yan M, Yun Y, Zhang J, et al
    MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer.
    Oncol Rep. 2017 Mar 13. doi: 10.3892/or.2017.5502.
    PubMed     Text format     Abstract available


  9. BAI Y, Xiao Y, Dai Y, Chen X, et al
    Stanniocalcin 1 promotes cell proliferation via cyclin E1/cyclindependent kinase 2 in human prostate carcinoma.
    Oncol Rep. 2017 Mar 13. doi: 10.3892/or.2017.5501.
    PubMed     Text format     Abstract available


  10. TAO T, Chen M, Jiang R, Guan H, et al
    Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Oncol Rep. 2017;37:1430-1436.
    PubMed     Text format     Abstract available


  11. ZHANG H, Du X, Sun TT, Wang CL, et al
    Lectin PCL inhibits the Warburg effect of PC3 cells by combining with EGFR and inhibiting HK2.
    Oncol Rep. 2017;37:1765-1771.
    PubMed     Text format     Abstract available


    February 2017
  12. YU H, Sun SQ, Gu XB, Wang W, et al
    Atorvastatin prolongs the lifespan of radiationinduced reactive oxygen species in PC-3 prostate cancer cells to enhance the cell killing effect.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5447.
    PubMed     Text format     Abstract available


  13. KONG Q, Chen XS, Tian T, Xia XY, et al
    MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.
    Oncol Rep. 2017;37:803-812.
    PubMed     Text format     Abstract available


    January 2017
  14. LIU Y, Qin Z, Yang K, Liu R, et al
    Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/beta-catenin signaling.
    Oncol Rep. 2017 Jan 17. doi: 10.3892/or.2017.5378.
    PubMed     Text format     Abstract available


  15. HE Y, Huang H, Farischon C, Li D, et al
    Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
    Oncol Rep. 2017 Jan 4. doi: 10.3892/or.2017.5353.
    PubMed     Text format     Abstract available


  16. LIU B, Gu X, Huang T, Luan Y, et al
    Identification of TMPRSS2-ERG mechanisms in prostate cancer invasiveness: Involvement of MMP-9 and plexin B1.
    Oncol Rep. 2017;37:201-208.
    PubMed     Text format     Abstract available


  17. SUN W, Guo L, Shao G, Liu X, et al
    Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-kappaB pathway.
    Oncol Rep. 2017;37:341-347.
    PubMed     Text format     Abstract available


    December 2016
  18. YIN H, Sheng Z, Zhang X, Du Y, et al
    Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
    Oncol Rep. 2016 Dec 2. doi: 10.3892/or.2016.5288.
    PubMed     Text format     Abstract available


    November 2016
  19. LI S, Wang C, Yu X, Wu H, et al
    miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.
    Oncol Rep. 2016 Nov 16. doi: 10.3892/or.2016.5250.
    PubMed     Text format     Abstract available


  20. JANG IS, Park JW, Jo EB, Cho CK, et al
    Growth inhibitory and apoptosis-inducing effects of allergen-free Rhus verniciflua Stokes extract on A549 human lung cancer cells.
    Oncol Rep. 2016;36:3037-3043.
    PubMed     Text format     Abstract available


  21. OHNISHI Y, Yasui H, Kakudo K, Nozaki M, et al
    Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.
    Oncol Rep. 2016;36:3058-3064.
    PubMed     Text format     Abstract available


    October 2016
  22. LAI X, Guo Y, Guo Z, Liu R, et al
    Downregulation of microRNA574 in cancer stem cells causes recurrence of prostate cancer via targeting REL.
    Oncol Rep. 2016 Oct 24. doi: 10.3892/or.2016.5196.
    PubMed     Text format     Abstract available


  23. XU L, Wang Z, He SY, Zhang SF, et al
    Bax-interacting factor-1 inhibits cell proliferation and promotes apoptosis in prostate cancer cells.
    Oncol Rep. 2016 Oct 14. doi: 10.3892/or.2016.5172.
    PubMed     Text format     Abstract available


  24. ZHANG W, Liu J, Qiu J, Fu X, et al
    MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII.
    Oncol Rep. 2016 Oct 3. doi: 10.3892/or.2016.5141.
    PubMed     Text format     Abstract available


    August 2016
  25. CHEN Y, Zhao J, Luo Y, Wang Y, et al
    Downregulated expression of miRNA-149 promotes apoptosis in side population cells sorted from the TSU prostate cancer cell line.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5047.
    PubMed     Text format     Abstract available


  26. ZHANG X, Wang L, Wang Y, Shi S, et al
    Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A/MDM2 expression.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5018.
    PubMed     Text format     Abstract available


  27. FIALOVA B, Luzna P, Gursky J, Langova K, et al
    Epigenetic modulation of AR gene expression in prostate cancer DU145 cells with the combination of sodium butyrate and 5'-Aza-2'-deoxycytidine.
    Oncol Rep. 2016 Aug 3. doi: 10.3892/or.2016.5000.
    PubMed     Text format     Abstract available


  28. HUANG S, Tang Y, Peng X, Cai X, et al
    Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs.
    Oncol Rep. 2016 Aug 2. doi: 10.3892/or.2016.4997.
    PubMed     Text format     Abstract available


    July 2016
  29. TIAN H, Zhou Y, Yang G, Geng Y, et al
    Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4942.
    PubMed     Text format     Abstract available


  30. PING H, Yang F, Wang M, Niu Y, et al
    IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer.
    Oncol Rep. 2016 Jul 7. doi: 10.3892/or.2016.4915.
    PubMed     Text format     Abstract available


    June 2016
  31. WANG D, Zhu L, Liao M, Zeng T, et al
    MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40.
    Oncol Rep. 2016 Jun 29. doi: 10.3892/or.2016.4910.
    PubMed     Text format     Abstract available


  32. KIM TD, Shin S, Janknecht R
    ETS transcription factor ERG cooperates with histone demethylase KDM4A.
    Oncol Rep. 2016;35:3679-88.
    PubMed     Text format     Abstract available


    May 2016
  33. GRAVINA GL, Marampon F, Sanita P, Mancini A, et al
    Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer.
    Oncol Rep. 2016 May 23. doi: 10.3892/or.2016.4832.
    PubMed     Text format     Abstract available


  34. YANG Y, Lu Y, Wang L, Mizokami A, et al
    Skp2 is associated with paclitaxel resistance in prostate cancer cells.
    Oncol Rep. 2016 May 13. doi: 10.3892/or.2016.4809.
    PubMed     Text format     Abstract available


  35. XU S, Yi XM, Tang CP, Ge JP, et al
    Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4791.
    PubMed     Text format     Abstract available


  36. ZHANG X, Tao T, Liu C, Guan H, et al
    Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4797.
    PubMed     Text format     Abstract available


    April 2016
  37. LI M, Wang YX, Luo Y, Zhao J, et al
    Hypoxia inducible factor-1alpha-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells.
    Oncol Rep. 2016 Apr 25. doi: 10.3892/or.2016.4766.
    PubMed     Text format     Abstract available


    March 2016
  38. LI F, Gu C, Tian F, Jia Z, et al
    miR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
    Oncol Rep. 2016 Mar 8. doi: 10.3892/or.2016.4663.
    PubMed     Text format     Abstract available


  39. KOU B, Liu W, He W, Zhang Y, et al
    Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway.
    Oncol Rep. 2016 Mar 3. doi: 10.3892/or.2016.4649.
    PubMed     Text format     Abstract available


    February 2016
  40. WANG X, Niu Z, Jia Y, Cui M, et al
    Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
    Oncol Rep. 2016 Feb 3. doi: 10.3892/or.2016.4611.
    PubMed     Text format     Abstract available


  41. TANG J, Xiao L, Cui R, Li D, et al
    CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-alpha/EGFR pathway in hypoxic androgenindependent prostate cancer cells.
    Oncol Rep. 2016;35:1153-1162.
    PubMed     Text format     Abstract available


  42. HUANG K, Tang Y, He L, Dai Y, et al
    MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Oncol Rep. 2016;35:887-895.
    PubMed     Text format     Abstract available


    January 2016
  43. YANG K, Shen J, Chen SW, Qin J, et al
    Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells.
    Oncol Rep. 2016 Jan 21. doi: 10.3892/or.2016.4582.
    PubMed     Text format     Abstract available


  44. KIM YR, Kang TW, To PK, Xuan Nguyen NT, et al
    HOXB13-mediated suppression of p21WAF1/CIP1 regulates JNK/c-Jun signaling in prostate cancer cells.
    Oncol Rep. 2016 Jan 15. doi: 10.3892/or.2016.4563.
    PubMed     Text format     Abstract available


    December 2015
  45. KANG M, Ho JN, Kook HR, Lee S, et al
    Theracurmin(R) efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4537.
    PubMed     Text format     Abstract available


  46. YANG F, Jiang X, Song L, Wang H, et al
    Quercetin inhibits angiogenesis through thrombospondin-1 upregulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo.
    Oncol Rep. 2015 Dec 9. doi: 10.3892/or.2015.4481.
    PubMed     Text format     Abstract available


    November 2015
  47. WANG L, Dong J, Wei M, Wen W, et al
    Selective and augmented beta-glucuronidase expression combined with DOX-GA3 application elicits the potent suppression of prostate cancer.
    Oncol Rep. 2015 Nov 26. doi: 10.3892/or.2015.4454.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: